Spinorphin as an endogenous inhibitor of enkephalin-degrading enzymes: roles in pain and inflammation
- PMID: 12470213
- DOI: 10.2174/1389203023380404
Spinorphin as an endogenous inhibitor of enkephalin-degrading enzymes: roles in pain and inflammation
Abstract
It is possible that enkephalins are involved in the pain-modulating mechanism in the spinal cord. Enkephalins, however, are short-lived, being rapidly degraded by various endogenous enzymes. Many substances that inhibit enkephalin-degradation have been investigated and it has been reported that some inhibitors (e.g. kelatorphan and RB101) alone showed anti-nociceptive activity. We found an endogenous factor that modulated enkephalin-degrading activity and purified it from bovine spinal cord based on its inhibitory activity toward enkephalin-degrading enzymes. Structural analysis revealed the factor to be Leu-Val-Val-Tyr-Pro-Trp-Thr and it was named spinorphin. It has been found that spinorphin inhibited the activity toward various enkephalin-degrading enzymes from monkey brain, especially dipeptidyl peptidase III (DPPIII, Ki=5.1 x 10(-7) M). Recently we reported that this inhibitor significantly inhibited bradykinin (BK)-induced nociceptive flexor responses. Importantly, the mode of inhibition to BK-responses by spinorphin was different from the case with morphine. The morphine-induced blockade of BK-response was attenuated by pertussis toxin treatment, whereas that of spinorphin was not. We also have reported roles for spinorphin in inflammation. Spinorphin significantly inhibited the functions of polymorphonuclear neutrophils (PMNs) by suppressing the binding of fMLF to its receptor on PMNs. Further, this inhibitor suppressed the carrageenan-induced accumulation of PMN in mouse air pouches after intravenous administration. These results indicate that spinorphin may be an endogenous anti-inflammatory regulator. The possible role of spinorphin and its analog as regulators in pain and inflammation will be discussed.
Similar articles
-
Inhibitory action of spinorphin, an endogenous regulator of enkephalin-degrading enzymes, on carrageenan-induced polymorphonuclear neutrophil accumulation in mouse air-pouches.Life Sci. 1998;62(19):1767-73. doi: 10.1016/s0024-3205(98)00138-6. Life Sci. 1998. PMID: 9585107
-
[Spinorphin, a new inhibitor of enkephalin-degrading enzymes derived from the bovine spinal cord].Masui. 1993 Oct;42(10):1497-503. Masui. 1993. PMID: 8230703 Japanese.
-
Spinorphin, an endogenous inhibitor of enkephalin-degrading enzymes, potentiates leu-enkephalin-induced anti-allodynic and antinociceptive effects in mice.Jpn J Pharmacol. 2001 Dec;87(4):261-7. doi: 10.1254/jjp.87.261. Jpn J Pharmacol. 2001. PMID: 11829145
-
RB101-mediated protection of endogenous opioids: potential therapeutic utility?CNS Drug Rev. 2007 Summer;13(2):192-205. doi: 10.1111/j.1527-3458.2007.00011.x. CNS Drug Rev. 2007. PMID: 17627672 Free PMC article. Review.
-
Enkephalin degrading enzymes: metalloproteases with high potential for drug development.Curr Pharm Des. 2012;18(2):220-30. doi: 10.2174/138161212799040547. Curr Pharm Des. 2012. PMID: 22229560 Review.
Cited by
-
Opiorphin: an endogenous human peptide with intriguing application in diverse range of pathologies.Inflammopharmacology. 2024 Oct;32(5):3037-3056. doi: 10.1007/s10787-024-01526-8. Epub 2024 Aug 20. Inflammopharmacology. 2024. PMID: 39164607 Review.
-
Salivary proteome of aphthous stomatitis reveals the participation of vitamin metabolism, nutrients, and bacteria.Sci Rep. 2021 Aug 2;11(1):15646. doi: 10.1038/s41598-021-95228-8. Sci Rep. 2021. PMID: 34341431 Free PMC article.
-
Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways.Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17979-84. doi: 10.1073/pnas.0605865103. Epub 2006 Nov 13. Proc Natl Acad Sci U S A. 2006. PMID: 17101991 Free PMC article.
-
Hemoglobins as new players in multiple sclerosis: metabolic and immune aspects.Metab Brain Dis. 2016 Oct;31(5):983-92. doi: 10.1007/s11011-016-9845-7. Epub 2016 May 28. Metab Brain Dis. 2016. PMID: 27234993 Review.
-
Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.Med Res Rev. 2006 Jan;26(1):88-130. doi: 10.1002/med.20044. Med Res Rev. 2006. PMID: 16216010 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases